| Field Name |
Data Description |
| Test Name |
Digoxin (Lanoxin) |
| Code |
DIG |
|
CPT Code |
80162 |
| Last Modified |
4/29/2015 1:14:00 PM |
| Test Name |
DIGOXIN ASSAY (3050) |
| Synonyms |
LANOXIN, DIG |
| Patient Preparation |
|
| Spec. Requirements |
Blood |
| Tube |
Lt. Green or Gold |
| Collection Volume |
3.0 mL Lt Green or 3.5 mL Gold |
| Storage |
Analyze fresh samples. 2-8C - 2 days, >= -20C - 7 days |
| Routine TAT |
4 hours |
| STAT TAT |
50 Minutes |
| Days Test Performed |
Daily |
| Performed by BHS |
All Hospitals |
| See Availability |
All shifts |
| Reference Lab |
N/A |
| Reference Lab Code |
|
| Clinical Use |
Cardiac glycoside used to treat cardiac arrhythmias. |
| Reference Range |
Therapeutic Level: 0.8 - 2.0 ng/mL |
| Critical Value |
>= 2.1 ng/mL |
|
Component |
Digoxin |
|
Reference Range |
0.8-2.0 ng/ml |
|
Critical Value |
>2.0 ng/ml |
 |
|
| Testing Sample Type |
Plasma or Serum |
| Min Lab Testing Volume |
0.5 mL (0.2 mL) |
| Special Handling |
Samples should be drawn 12 hours after oral administration of Digoxin or 6 hours after IV administration. |
| Lab Notes |
If sample is collected in a gelled tube, sample cannot be used for any TDM / Drug assays if not separated from the gel within 24 hours of collection. |
| Methodology |
Turbidimetric inhibition immunoassay |
| Limitations |
Digibind therapy can interfere with this assay. |
